TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biomedola AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
663
|
784
|
646 |
| Financial expenses |
42
|
0
|
0 |
| Earnings before taxes |
962
|
549
|
496 |
| EBITDA |
320
|
524
|
496 |
| Total assets |
4,014
|
3,389
|
3,018 |
| Current assets |
2,597
|
2,077
|
1,714 |
| Current liabilities |
129
|
140
|
99 |
| Equity capital |
3,682
|
3,037
|
2,718 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
89.6%
|
90.1% |
| Turnover per employee |
663
|
784
|
646 |
| Profit as a percentage of turnover |
145.1%
|
70.0%
|
76.8% |
| Return on assets (ROA) |
25.0%
|
16.2%
|
16.4% |
| Current ratio |
2013.2%
|
1483.6%
|
1731.3% |
| Return on equity (ROE) |
26.1%
|
18.1%
|
18.2% |
| Change turnover |
-95
|
135
|
124 |
| Change turnover % |
-13%
|
21%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.